Guardant Health
282 hedge funds and large institutions have $3.32B invested in Guardant Health in 2024 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 84 increasing their positions, 91 reducing their positions, and 42 closing their positions.
64% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 42
44% more capital invested
Capital invested by funds: $2.3B → $3.32B (+$1.02B)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
9% more funds holding
Funds holding: 258 → 282 (+24)
2.32% more ownership
Funds ownership: 93.82% → 96.14% (+2.3%)
8% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 91
51% less call options, than puts
Call options by funds: $26.4M | Put options by funds: $53.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$81.7M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$54.3M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$45.1M |
| 4 |
Millennium Management
New York
|
+$22M |
| 5 |
Morgan Stanley
New York
|
+$21.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Cadian Capital Management
New York
|
-$62M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$34.9M |
| 3 |
Man Group
London,
United Kingdom
|
-$20M |
| 4 |
DM
Deerfield Management
New York
|
-$16.3M |
| 5 |
Squarepoint
New York
|
-$16.2M |
GH Hedge Fund Activity: Q2 2024 in Review
282 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q2 2024, worth a combined $3.32B — up 44% from $2.3B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new GH positions and 42 closed out — a net gain of 27 holders — while 84 added to existing stakes and 91 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $81.7M. The largest seller was Cadian Capital Management, cutting an estimated $62M.
- 282 institutional investors held Guardant Health (GH) as of Q2 2024, up from 258 in Q1 2024.
- Funds reported $3.32B of Guardant Health stock for Q2 2024, up 44% quarter-over-quarter.
- 69 funds opened new Guardant Health positions in Q2 2024 and 42 closed out, a net change of +27 holders.
- The largest Guardant Health buyer in Q2 2024 was Wellington Management Group, an estimated $81.7M added.
- The largest Guardant Health seller in Q2 2024 was Cadian Capital Management, an estimated $62M sold.
Based on aggregated 13F filings for Q2 2024.